Global Microbial Products Market Size, Share, Forecast Report, 2020-2027

A microbe is a microscopic living organism, such as a bacteria, yeast, or fungus. Microbial products are produced by microbes and industrial microbiology is a branch of biotechnology which deals with the field. Microbes have been utilized for centuries to produce bread, cheese, wine, vinegar.. Medicinal microbiology include production of enzymes, antibiotics, nutrients such as amino acids, vitamins, and organic acids, chemotherapeutic agents, vaccines etc. Penicillin production is a classic example of microbial product for medicinal use. Beer was the first commercial product which dates back to around 1750 BC developed by the ancient Sumerians. Another application of microbial products is the manufacture of solvents and reagents such as ethanol, lactic acid, butanol etc. Synthesis of amino acids such as are L-Methionine, L-Lysine, L-Tryptophan, L-Glutamic acid etc. are another use of industrial microbiology for production of microbial products.

Fermentation technology is the most applied method for manufacturing of microbial products which converts sugars into gas, alcohols or acids. Advances in fermentation technology has the potential to change the way microbial products are produced. Until recently, fermentation depended on limited raw materials and microbial strains which had a low yield. However, genetic recombinant technology is being used to manipulate microbes to increase their efficiency and make them capable to use a wide variety of raw materials. Reengineered microbes can produce microbial products more economically and naturally. Biotechnology has advanced to the level of engineering microorganisms to increase the yield of microbial products using ways such as introduction of mutations into an organism, gene amplification using plasmids, and vectors.
Segments:

The global microbial products market is segmented on the basis of types, source, applications and end users. Based on types, the market has been segmented as enzymes, polysaccharides, nutrients (amino acids, nucleotides, vitamins, and organic acids, others), chemotherapeutic agents, antibiotics, vaccines, others. Based on the source, the market has been segmented as bacterial, viral, fungi and others. Based on the applications, the market has been segmented as pharmaceutical, diagnostic, biotechnology and others. Based on the end users, the market has been segmented into pharmaceutical and biotechnological industries, hospitals & clinics, diagnostic labs, research & academics and others.
Key players of Global Microbial products market:

Key players profiled in the report are Amgen Inc., Merck & Co.,Inc., Valent BioSciences Corp., GlaxoSmithKline plc, Pfizer Inc., bioMérieux SA, Ajinomoto Co.Inc., Sanofi S.A, Novartis AG, NovaDigm Therapeutics, Kyowa Hakko Bio Co., Ltd. and others.